Press Release Apr 11 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
This topical solution is intended for the treatment of fungal toenail infections. The manufacturing will take place at Zydus's facility in Changodar, Ahmedabad. The press release highlights that Tavaborole had annual sales of a specific amount in the United States as of early this year.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Apr 10 2023
- Press Release Apr 06 2023
- Press Release Mar 28 2023
- Press Release Mar 25 2023
- Press Release Mar 24 2023
Later from Zydus Lifesciences
- Press Release Apr 15 2023
- Press Release Apr 18 2023
- Press Release Apr 19 2023
- Press Release Apr 20 2023
- Zydus Lifesciences Limited Press Release Apr 24 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences